JMP Securities Reiterates Market Outperform Rating on Aquestive Therapeutics (AQST)

October 8, 2024 8:10 AM EDT Send to a Friend
JMP Securities analyst Jason Butler reiterated a Market Outperform rating and $9.00 price target on Aquestive Therapeutics (NASDAQ: AQST).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login